Study of Zonisamide in Early Parkinson Disease

NCT01766128 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Practical problems

Conditions

Parkinson Disease

Interventions

DRUG: Zonisamide
DRUG: Placebo

Sponsor

Mazandaran University of Medical Sciences